Code of Maryland Regulations
Title 30 - MARYLAND INSTITUTE FOR EMERGENCY MEDICAL SERVICES SYSTEMS (MIEMSS)
Subtitle 08 - DESIGNATION OF TRAUMA AND SPECIALTY REFERRAL CENTERS
Chapter 30.08.12 - Perinatal and Neonatal Referral Center Standards
Section 30.08.12.12 - Medications

Universal Citation: MD Code Reg 30.08.12.12
Current through Register Vol. 51, No. 19, September 20, 2024

III

IV

A hospital shall have:

A. Emergency medications, as listed in the current Neonatal Resuscitation Program (NRP) guidelines, shall be immediately available in the delivery area and neonatal units;

E

E

B. The following medications shall be immediately available to the neonatal units:

(1) Antibiotics, anticonvulsants, and emergency cardiovascular drugs; and

(2) Surfactant, prostaglandin E1;

E

E

C. All emergency resuscitation medications to initiate and maintain resuscitation, in accordance with current Advanced Cardiac Life Support (ACLS) guidelines of the American Heart Association (AHA), shall be immediately available in the delivery area;

E

E

D. The following medications shall be immediately available for management of obstetrical hemorrhage in the delivery area and postpartum floor:

(1) Oxytocin (Pitocin);

(2) Methylergonovine (Methergine);

(3) Misoprostol (Cytotec);

(4) Carboprost tromethamine (Hemabate); and

(5) Tranezamic acid (TXA); and

E

E

E. The following medications shall be immediately available for management of hypertensive crisis in all obstetrical care areas:

(1) Hydralazine;

(2) Labetalol; and

(3) Nifedipine.

E

E

Disclaimer: These regulations may not be the most recent version. Maryland may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.